Summer Sale
50% off Premium Yearly
00days
00hrs
00mins
00secs
Opinions John Sinkins, CFA
Spectrum Pharmaceuticals IncSPPITRADEOct 07, 2003
They have an anti-cancer treatment. Signed a licensing agreement with a major German firm for marketing of their drug.
John Sinkins, CFAUnknown
$6.97
Stock price when the opinion was issued
$1.03
As of Jul 31, 2023. Market Open.
biotechnologypharmaceutical
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.
